Your browser doesn't support javascript.
loading
Case report of belt electrode-skeletal muscle electrical stimulation for acute heart failure with severe obesity: a novel therapeutic option for acute phase rehabilitation.
Mochizuki, Yuto; Jimba, Takahiro; Yasukawa, Syota; Katsura, Aritomo; Fukuda, Akira; Ando, Jiro.
Afiliação
  • Mochizuki Y; Department of Rehabilitation Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
  • Jimba T; Department of Cardiovascular Medicine, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Yasukawa S; Department of Cardiovascular Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
  • Katsura A; Department of Rehabilitation Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
  • Fukuda A; Department of Cardiovascular Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
  • Ando J; Department of Rehabilitation Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
Front Cardiovasc Med ; 11: 1344137, 2024.
Article em En | MEDLINE | ID: mdl-38525190
ABSTRACT

Background:

Belt electrode skeletal muscle electrical stimulation (B-SES) is an emerging therapy anticipated to yield more favorable outcomes than conventional neuromuscular electrical stimulation (NMES), owing to its larger stimulation area. However, information on its efficacy and safety in patients with heart failure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m2 was admitted to our hospital for acute heart failure due to dilated cardiomyopathy. The patient required prolonged catecholamine support owing to poor cardiac function, and heart transplantation was considered. We initiated a mobilization program, but the patient's mobility was highly limited due to severe obesity and symptomatic orthostatic hypotension. B-SES was introduced to accomplish weight loss and early ambulation. We applied an intensive monitoring program for safe use and modulated the intensity of B-SES according to physical function. During the B-SES program, the patient's body weight decreased from 89.6 kg to 78.6 kg. Sequential evaluations of body composition and skeletal muscle ultrasonography revealed improved muscle mass, quality, and physical function. Furthermore, we explored the workload of B-SES using expiratory gas analysis. No adverse events were observed during B-SES.

Discussion:

We successfully used B-SES to improve muscle function and morbidity in the treatment of acute heart failure. B-SES could be an option for patients with heart failure who have limited mobility and obesity.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article